Hostname: page-component-848d4c4894-pjpqr Total loading time: 0 Render date: 2024-07-01T11:17:12.962Z Has data issue: false hasContentIssue false

Group B streptococcus infection in pregnancy: an update

Published online by Cambridge University Press:  01 February 1999

Geralyn C O'Reilly
Affiliation:
University of Washington Medical Center, Department of Obstetrics and Gynecology, Seattle, Washington.
Jane E Hitti
Affiliation:
University of Washington Medical Center, Department of Obstetrics and Gynecology, Seattle, Washington.
Thomas J Benedetti
Affiliation:
University of Washington Medical Center, Department of Obstetrics and Gynecology, Seattle, Washington.

Abstract

Group B streptococcus (GBS), or Streptococcus agalactiae, has been a continuing focus of debate in the paediatric and obstetric worlds. The organism has emerged as the leading cause of early-onset neonatal sepsis. With an average of 20% of mothers being carriers for the organism (range from 15–40%), the following questions remain to be answered:

1 How best to screen for GBS and which protocol to use?

2 How best to counsel patients who are GBS carriers?

3 What is the cost effectiveness of the screening protocols?

Type
Research Article
Copyright
© 1999 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)